-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Neutral on Agios Pharmaceuticals, Raises Price Target to $36

Benzinga·04/06/2026 18:20:13
Listen to the news
JP Morgan analyst Tessa Romero maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Neutral and raises the price target from $31 to $36.